Chongqing Claruvis Pharmaceutical Co., Ltd.
Chongqing Claruvis Pharmaceutical Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity | Upper Limb Spasticity | Recruiting | Phase 3 | 2026-04-02 | NCT07478822 | |
| A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults | Upper Limb Spasticity | Recruiting | Phase 2 / Phase 3 | 2026-01-22 | NCT06783114 |